Sort:
Issue
Age-related increase of IGFBP5 promotes mitophagy and apoptosis in thymic epithelial cells
Journal of Army Medical University 2024, 46(6): 567-577
Published: 30 March 2024
Abstract PDF (3.7 MB) Collect
Downloads:1
Objective

To investigate the role and underlying mechanism of insulin like growth factor binding protein 5 (IGFBP5), a gene up-regulated with age in thymic epithelial cells, in the pathogenesis of thymic involution.

Methods

Different gene expression analysis was applied to published human thymic stromal cells single-cell RNA-seq data set (GSE147520) to identify genes up-regulated with aging, and IGFBP5 was screened out as the most significant gene. Mfuzz trends analysis was employed to fine the genes with similar expression pattern as IGFBP5. Gene ontology (GO) enrichment analysis was conducted to annotate the function of the common trend gene set associated with IGFBP5. Protein sequence alignment tool was utilized to analyze the human-mouse homology of IGFBP5 protein sequence. Then NIH gene database was consulted to investigate the expression pattern of IGFBP5 in various organs and tissues of both humans and mice. Immunohistochemical assay was performed on mouse thymus samples to examine the expression pattern of IGFBP5. After a mouse thymic epithelial cell line with IGFBP5 overexpression was constructed, transmission electron microscopy was used to observe the morphological changes in the mitochondria, Western blotting was employed to detect altered protein components related to mitochondrial autophagy, including microtubule associated protein 1 light chain 3 beta (LC3B), PTEN induced kinase 1 (PINK1), Parkin RBR E3 ubiquitin protein ligase (Parkin), and BCL2 interacting protein 3 (BNIP3), in both whole cell extracts and isolated mitochondria, and cleaved-Capase3 was used to estimate cell apoptosis. Double immunofluorescence staining was performed to observe the intracellular localization of the mitophagy markers as described above with mitochondria probe (MitoTracker). Flow cytometry was used to detect the apoptotic rates of the cell lines.

Results

IGFBP5 was identified with the highest increase in gene expression in human thymic epithelial cells with ageing, and the genes with similar expression pattern as IGFBP5 were related to mitochondrial metabolism pathways. Protein sequence alignment demonstrated a high conservation between human and mouse IGFBP5 protein sequences. IGFBP5 was moderately expressed in both human and mouse thymus tissues. Mouse thymus showed an age-dependent increase in IGFBP5 expression in thymic epithelial cells like human. In the mouse thymic epithelial cell line with IGFBP5 overexpression, transmission electron microscopy indicated an increased mitophagy bodies, Western blotting revealed up-regulated protein levels of LC3B, PINK1, and Parkin in the mitochondrial and cellular components, while no significant difference was observed for BNIP3. Double immunofluorescence staining demonstrated that increased cytoplasmic expression of LC3B, PINK1, and Parkin were co-localized with mitochondria. Western blotting confirmed that Cleaved-Caspase3 level was elevated, as a marker of cell apoptosis in IGFBP5 overexpression mouse thymic epithelial cell line. Flow cytometry indicated that IGFBP5 overexpression cell line had an increased proportion of apoptotic cells.

Conclusion

Increased expression of IGFBP5 with aging promotes mitochondrial autophagy and apoptosis in thymic epithelial cells, and then leads to thymic involution. IGFBP5 might be a potential target in the intervention of thymic aging and reconstruction of human immune system.

Issue
Clinical indicators and immunological characteristics of COVID-19: a retrospective analysis of 123 cases
Journal of Army Medical University 2023, 45(7): 689-698
Published: 15 April 2023
Abstract PDF (2.2 MB) Collect
Downloads:0
Objective

To study the relevant clinical indicators and immunological characteristics of patients with different levels of Corona Virus Disease 2019(COVID-19).

Methods

A total of 123 patients with confirmed COVID-19 admitted to Wuhan Huoshenshan Hospital from February 5 to April 10, 2020 were enrolled as the study objects. According to Novel Coronavirus Pneumonia Treatment Protocol(6th Edition), they were divided into recovery(n=69), severe(n=45), and death(n=9)groups. Their electronic medical records were collected, and basic data, clinical symptoms, and results of laboratory examinations were analyzed statistically. A cross-sectional study was conducted on the expression levels of serum cytokines, T cell characteristics, and PD-1 expression on T cells. All data were analyzed using GraphPad Prism 8.0 software.

Results

There were 74 male and 49 female COVID-19 patients, with a median age of 63.94 years in this study, and among them, 79 were over 60 years old. Plasma C-reactive protein(CRP), lactate dehydrogenase(LDH), hydroxybutyrate dehydrogenase(HBHD), cystatin C(CysC), and procalcitonin(PCT)were significantly elevated in the severe disease and death groups(P<0.05). The 2 groups also had obviously higher serum levels of IL-2, IL-6, IL-8, IL-10 and IL-17 than the recovery group(P<0.05). The patients from the death group had the lowest peripheral blood lymphocyte count and the highest neutrophil count(P<0.05). The expression level of PD-1 in CD4+ T cells and CD8+ T cells was notably higher in the severe and death groups than the recovery group(P<0.05).

Conclusion

Age is associated with the level of COVID-19. And the levels of cytokines such as IL-6 and IL-8, decrease of T lymphocytes and exhaustion of T cell function are closely correlated with the severity of COVID-19.

Review Article Issue
Nanoparticle targeting cGAS-STING signaling in disease therapy
Nano Research 2024, 17(8): 7315-7336
Published: 15 June 2024
Abstract PDF (3.4 MB) Collect
Downloads:209

The cyclic guanosine monophosphate-adenosine monophosphate synthase-stimulator of interferon (IFN) genes (cGAS-STING) signaling pathway is crucial for sensing abnormal DNA accumulation in the cytoplasm. Once binds to abnormal DNA, cGAS catalyzes the production of second messenger cyclic dinucleotides, followed by the activation of downstream STING. This activation induces the expression of type I interferon and other inflammatory cytokines, ultimately initiating an immune response. Due to the involvement of the cGAS-STING pathway in various diseases, including infection, tumor, autoimmune disease and kidney disease, ongoing research is focused on developing drugs and treatment methods to target and regulate this pathway. With the development of nanotechnology, nanomedicines targeting cGAS-STING signaling are of great significance in clinical applications due to their targeted delivery, controlled drug release, improved solubility, multifunctionality, and enhanced stability. This comprehensive review focuses on the most recent progress of nanoplatforms targeting cGAS-STING in disease therapy, aiming to provide references and guidelines for further design and optimization of nanomedicines.

Total 3